ARTICLE | Clinical News
Oxygent perflubron emulsion: Began Phase IIb trial in surgery. Oxygent is being co-developed by ALLP and Ortho Biotech Inc.
October 30, 1995 8:00 AM UTC
Alliance Pharmaceutical Corp. (ALLP), San Diego Product: Oxygent perflubron emulsion Use: Blood substitute Status: Began Phase IIb trial in surgery. Oxygent is being co-developed by ALLP and Ortho Bi...